Back
Speaker illustration

Assistant Professor Anil Sahin

Cumhuriyet University, Sivas (Türkiye)

Member of:

Heart Failure Association

Dr Sahin is a graduate of Ege University Faculty of Medicine. He completed his specialization in the Department of Cardiology at Sivas Cumhuriyet University and now serves as a faculty member in the same department at Cumhuriyet University, where he is actively engaged in research and teaching. Dr Sahin's researches focuses on the epidemiology of heart failure in Türkiye. He completed the Heart Failure Certification Program by the Turkish Society of Cardiology and was elected as a Fellow of the HFA in 2023. Dr. Sahin is also a part of the HFA Young and serves as one of the ambassadors from Türkiye, actively participating in the organization's activities. Dr Sahin is a member of the HFA Lung, Sleep, and Pulmonary Hypertension Committee.

Presentations

Addition of sodium-glucose cotransporter-2 inhibitors on steroidal mineralocorticoid receptor antagonists eliminates hyperkalemia risk in diabetic heart failure patients with chronic kidney disease

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Congestion, SGLT2 inhibitors and novel therapies

Access
Like
Thumbnail

The risk of hyperkalemia by baseline mineralocorticoid receptor antagonists and sodium-glucose cotransporter-2 inhibitors use in heart failure patients with diabetic advanced kidney disease

Event: Heart Failure 2025

Topic: Comorbidities

Session: Cardiometabolic and multisystem interactions in heart failure

Access
Like
Thumbnail

Effect of angiotensin converting enzyme inhibitors versus angiotensin receptor blockers on all-cause mortality in heart failure patients receiving quadruple guideline directed medical therapy

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Tailored therapeutics advances in heart failure

Access
Like
Thumbnail

Impact of defibrillators on mortality in patients with quadruple guideline-directed medical therapy: a propensity score-matched study

Event: Heart Failure 2024

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Acute, advanced and worsening heart failure: prognostic aspects

Access
Like
Thumbnail

Survival analysis in heart failure and end-stage chronic kidney disease: a propensity score matched study comparing peritoneal dialysis and hemodialysis

Event: Heart Failure 2024

Topic: Comorbidities

Session: Treating heart failure with diabetes and renal disease

Access
Like
Thumbnail

How can we increase adherence to medical treatment in heart failure patients? A questionnaire study

Event: Heart Failure 2024

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic heart failure - pathophysiology and mechanisms 13

Access
Like
Thumbnail

Is bendopnea associated with atrial fibrillation in heart failure patients with reduced ejection fraction?

Event: Heart Failure 2023

Topic: Clinical

Session: ePosters in chronic heart failure 3

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources